Kim P. Kamdar, Director at OBALON THERAPEUTICS INC (OBLN), bought 109,890 shares at $1.82 ($200K) on 2018-08-23, disclosed to the SEC on 2018-08-27.
Open-market purchase of $200k OBLN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.82 | 54,945 | $100K | 50.0% |
| 2 | $1.82 | 54,945 | $100K | 50.0% |
| Total | $1.82 avg | 109,890 | $200K | 100% |
| Filing → |
| EVFM | BUY | 2021-06-21 | $12K | — | Filing → |
| EVFM | BUY | 2020-06-16 | $15K | — | Filing → |
| OBLN | BUY | 2019-08-08 | $50K | — | Filing → |